Company news

Memphasys Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Extension of Convertible Notes

February 28, 2025

Felix Data lock complete and regulatory submission commenced

February 23, 2025

Leading Brazilian Andrology Clinic to test Felix System

February 16, 2025

Felix Clinical Trial complete, Data Lock expected in 2 weeks

February 10, 2025

Publication Highlights Diagnostic Potential of RoXsta TM

January 15, 2025

Heranova Felix System Utilisation Testing commences in China

January 5, 2025

Bovine Study commences to assess RoXsta antioxidant system

December 19, 2024

Felix Clinical Registration Study completed, expanding mkt

December 17, 2024

Letter of Intent with Heranova for Felix System Distribution

December 11, 2024

Order for Felix System to Evaluate Suitability in UAE

December 4, 2024

RoXsta System's Potential in Cattle Breeding being Explored

December 4, 2024

Felix Clinical Trial Reaches 95% Completion

November 17, 2024

RoXsta System Secures Provisional Patent Approval

November 14, 2024

Completion of Placement and SPP offer

November 5, 2024

MEM Investor Presentation

October 25, 2024

Felix Trial registration update

October 24, 2024

Equine study commences with 12mth commercialisation expected

October 17, 2024

Prospectus

September 20, 2024

Short term loan facility

September 17, 2024

Positive initial study results - Felix equine application

September 15, 2024

Reinstatement to Official Quotation

September 12, 2024

A$2 million capital raising

September 12, 2024

Voluntary Suspension

September 10, 2024

Response to ASX Query

September 6, 2024

Equine fertility study positions Felix as leading technology

September 3, 2024

Felix sales clinical trial and Oxidative Stress devel update

July 23, 2024

Animal activity update - oxidative stress measurement system

July 19, 2024

Dr David Ali appointed full-time Chief Executive Officer

June 5, 2024

Investor Presentation

May 21, 2024

Felix Japanese trial provides sperm preparation benefits

May 20, 2024

2024 Investor Presentation

May 9, 2024

Felix TM System Sales Orders Accelerate in Japan

March 17, 2024

AI-Port Update - Spring Field Trial Yields Positive Results

January 24, 2024

Vitrolife distribution agreement expands into Canada and NZ

January 1, 2024

$4.2m raise to pursue commercial opportunities with Felix

December 3, 2023

Board and executive transition and capital raise

November 29, 2023

Felix System records 10 new live births in India

September 14, 2023

Vitrolife sign Felix distribution agreement for Japanese mkt

August 6, 2023

Felix considered best method to treat cryopreserved semen

June 5, 2023

Japan first commercial sale and first baby born using Felix

April 2, 2023

KOL testings demonstrate Felix System outperforms DGC

February 6, 2023

FELIX System commercialisation, regulatory plan and trial

October 23, 2022

Rights Issue Closure and Shortfall Notification

September 19, 2022

$3.36 capital raising to accelerate FELIX commercialisation

August 16, 2022

Suspension from Official Quotation

July 29, 2022

Monash IVF clinical study enrols first patient using FELIX

June 28, 2022

Felix System commercialisation update

June 8, 2022

Follow up sales of FelixTM System

March 30, 2022

MEM Achieves ISO 13485 Compliance

March 13, 2022

Appendix 4D and Half Year Report and Accounts

February 25, 2022

← Newer news releases · Older news releases →

Decks

The 5 newest of 20 decks. Every deck is listed under its year.